Lisata Therapeutics Valuation
| LSTA Stock | USD 2.88 0.04 1.41% |
Based on Macroaxis valuation methodology, the firm appears to be undervalued. Lisata Therapeutics secures a last-minute Real Value of $5.01 per share. The latest price of the firm is $2.88. Our model forecasts the value of Lisata Therapeutics from analyzing the firm fundamentals such as Current Valuation of (11.5 M), return on equity of -0.44, and Shares Owned By Insiders of 19.12 % as well as examining its technical indicators and probability of bankruptcy. Key fundamental drivers impacting Lisata Therapeutics' valuation include:
Price Book 0.7176 | Enterprise Value -11.5 M | Enterprise Value Ebitda 0.8161 |
Undervalued
Today
Please note that Lisata Therapeutics' price fluctuation is moderately volatile at this time. Calculation of the real value of Lisata Therapeutics is based on 3 months time horizon. Increasing Lisata Therapeutics' time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Lisata Therapeutics is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Lisata Stock. However, Lisata Therapeutics' intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 2.88 | Real 5.01 | Target 11.83 | Hype 2.88 | Naive 2.93 |
The real value of Lisata Stock, also known as its intrinsic value, is the underlying worth of Lisata Therapeutics Company, which is reflected in its stock price. It is based on Lisata Therapeutics' financial performance, growth prospects, management team, or industry conditions. The intrinsic value of Lisata Therapeutics' stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of Lisata Therapeutics helps investors to forecast how Lisata stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Lisata Therapeutics more accurately as focusing exclusively on Lisata Therapeutics' fundamentals will not take into account other important factors: Traditionally, analysts and sophisticated investors use multiple methods for valuing a cash-flow-generating entity or its stock. For example, some money managers use Lisata Therapeutics' intrinsic value based on its ongoing forecasts of Lisata Therapeutics' financial statements. In contrast, other private, professional wealth advisors use a multiplier approach by looking to relative value analysis against Lisata Therapeutics' closest peers. If more than one evaluation category is relevant for Lisata Therapeutics we suggest using both methods to arrive at a better estimate.
Lisata Therapeutics Cash |
|
Lisata Valuation Trend
Comparing Lisata Therapeutics' enterprise value against its market capitalization is a good way to estimate the value of Lisata Therapeutics uage its performance over time. This information may sometimes be enough for investors to make reasonable market timing decisions.
Lisata Therapeutics Total Value Analysis
Lisata Therapeutics is now anticipated to have valuation of (11.5 M) with market capitalization of 24.18 M, debt of 305 K, and cash on hands of 72.99 M. The negative valuation of Lisata Therapeutics may imply that the market is not capable to price the future growth of the company or it is pricing it at zero value. It may also suggest that takeover valuation may not have captured all of the outstanding financial obligations of the company both on and off balance sheet. Investors should vigilantly validate all of the Lisata Therapeutics fundamentals.| Takeover Price | Market Cap | Debt Obligations | Cash |
(11.5 M) | 24.18 M | 305 K | 72.99 M |
Lisata Therapeutics Asset Utilization
One of the ways to look at asset utilization of Lisata is to check how much profit was generated for every dollar of assets it reports. Lisata Therapeutics secures a negative usage of assets of -0.29 %, losing $0.002872 for each dollar of assets held by the firm. Inadequate asset utilization conveys that the company is being less effective with each dollar of assets it secures. Strictly speaking, asset utilization of Lisata Therapeutics shows how discouraging it operates for each dollar spent on its assets.Lisata Therapeutics Ownership Allocation
The market capitalization of Lisata Therapeutics is $24.18 Million. Lisata Therapeutics secures 19.12 % of its outstanding shares held by insiders and 9.07 % owned by institutional investors. Note, that even with negative profits, if the true value of the firm is larger than the current market value, you may still be able to generate positive returns on investment in this company.Lisata Therapeutics Profitability Analysis
Net Loss for the year was (20.84 M) with profit before overhead, payroll, taxes, and interest of 0.Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Lisata Therapeutics' worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Lisata Therapeutics and how it compares across the competition.
About Lisata Therapeutics Valuation
The stock valuation mechanism determines Lisata Therapeutics' current worth on a weekly basis. Our valuation model uses a comparative analysis of Lisata Therapeutics. We calculate exposure to Lisata Therapeutics's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Lisata Therapeutics's related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | -189 K | -179.6 K | |
| Pretax Profit Margin | (0.42) | (0.44) | |
| Operating Profit Margin | (0.43) | (0.45) | |
| Net Loss | (0.40) | (0.42) | |
| Gross Profit Margin | 0.60 | 0.74 |
Lisata Therapeutics Growth Indicators
Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines.
| Common Stock Shares Outstanding | 8.1 M |
Lisata Therapeutics Current Valuation Indicators
Valuation refers to the process of determining the present value of Lisata Therapeutics and all of its assets. It can be calculated using a number of techniques. As many analysts who try to value Lisata we look at many different elements of the entity such as Lisata's management, its prospective future earnings, the current market value of the company's assets, as well as its capital structure formation.
Valuations are an essential part of business, for companies themselves, but also for investors. For companies, such as Lisata Therapeutics, valuations can help measure their progress and success and can help them track their performance in the market compared to others. In addition, investors can use Lisata Therapeutics' valuations to help determine the worth of potential investments. They can do this by using data and information made public by a company. Regardless of who the valuation is for, it essentially describes Lisata Therapeutics' worth.Complementary Tools for Lisata Stock analysis
When running Lisata Therapeutics' price analysis, check to measure Lisata Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Lisata Therapeutics is operating at the current time. Most of Lisata Therapeutics' value examination focuses on studying past and present price action to predict the probability of Lisata Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Lisata Therapeutics' price. Additionally, you may evaluate how the addition of Lisata Therapeutics to your portfolios can decrease your overall portfolio volatility.
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing |